Quick Answer
enVVeno Medical Corp reported Total Revenue of $31.2 thousand for fiscal year 2019.
enVVeno Medical Corp — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Revenue (ASC 606) | — | — | — | — | — | — |
| Net Income | -$19.47M +10.8% |
-$21.82M +7.2% |
-$23.52M +4.7% |
-$24.67M -49.3% |
-$16.53M -80.9% |
-$9.14M -19.8% |
| Diluted EPS | -$33.06 +25.8% |
-$44.53 -2231.4% |
-$1.91 +13.2% |
-$2.20 | — | — |
| Total Assets | $29.56M -34.2% |
$44.95M -7.6% |
$48.63M +16.7% |
$41.66M -27.8% |
$57.70M +447.5% |
$10.54M +206.8% |
| Cash and Equivalents | $3.06M +74.7% |
$1.75M -51.5% |
$3.62M -20.5% |
$4.55M -91.7% |
$54.73M +486.3% |
$9.33M +614.1% |
| Stockholders Equity | $27.13M -35.6% |
$42.16M -8.7% |
$46.20M +19.3% |
$38.73M -28.8% |
$54.40M +666.5% |
$7.10M +617.0% |
| R&D Expense | $9.98M -18.5% |
$12.25M -9.8% |
$13.58M +37.0% |
$9.91M +73.1% |
$5.73M +34.7% |
$4.25M +92.7% |
| Operating Income | -$20.90M +12.3% |
-$23.83M +5.6% |
-$25.24M -1.2% |
-$24.93M -47.6% |
-$16.89M -84.9% |
-$9.14M -19.0% |
| Gross Profit | — | — | — | — | — | — |
| Shares Outstanding | 656,000 +30.9% |
501,000 -96.2% |
13.32M +40.6% |
9.47M +0.0% |
9.47M +272.6% |
2.54M +254.3% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | March 31, 2019 | $31.2K | +0.6% | -25.0% |
| Revenue (ASC 606) | March 31, 2019 | $31.2K | +0.6% | -25.0% |
| Net Income | September 30, 2025 | -$4.54M | +19.5% | +32.2% |
| Diluted EPS | September 30, 2025 | -$0.23 | +34.3% | +30.3% |
| Total Assets | September 30, 2025 | $32.35M | -35.8% | -11.6% |
| Cash and Equivalents | September 30, 2025 | $1.54M | -91.4% | -24.5% |
| Stockholders Equity | September 30, 2025 | $29.45M | -37.8% | -10.9% |
| R&D Expense | September 30, 2025 | $2.58M | -9.6% | -10.6% |
| Operating Income | September 30, 2025 | -$4.88M | +20.9% | +30.7% |
| Gross Profit | March 31, 2019 | $31.2K | — | -25.0% |
| Shares Outstanding | September 30, 2025 | 20.22M | +15.3% | +5.0% |
- enVVeno Medical Corp reported Total Revenue of $31.2 thousand for fiscal year 2019.
- enVVeno Medical Corp showed a decrease of -83.3% in Total Revenue compared to the prior fiscal year.
- enVVeno Medical Corp reported Revenue (ASC 606) of $31.2 thousand for fiscal year 2019.
- enVVeno Medical Corp showed a decrease of -83.3% in Revenue (ASC 606) compared to the prior fiscal year.
- enVVeno Medical Corp reported Net Income of -$19.47 million for fiscal year 2025.
- enVVeno Medical Corp showed an increase of +10.8% in Net Income compared to the prior fiscal year.
- enVVeno Medical Corp reported Diluted EPS of $33.06 per share (loss) for fiscal year 2025.
- enVVeno Medical Corp showed an increase of +25.8% in Diluted EPS compared to the prior fiscal year.
- enVVeno Medical Corp reported Total Assets of $29.56 million for fiscal year 2025.
- enVVeno Medical Corp showed a decrease of -34.2% in Total Assets compared to the prior fiscal year.
- enVVeno Medical Corp reported Cash and Equivalents of $3.06 million for fiscal year 2025.
- enVVeno Medical Corp showed an increase of +74.7% in Cash and Equivalents compared to the prior fiscal year.
- enVVeno Medical Corp reported Stockholders Equity of $27.13 million for fiscal year 2025.
- enVVeno Medical Corp showed a decrease of -35.6% in Stockholders Equity compared to the prior fiscal year.
- enVVeno Medical Corp reported R&D Expense of $9.98 million for fiscal year 2025.
- enVVeno Medical Corp showed a decrease of -18.5% in R&D Expense compared to the prior fiscal year.
- enVVeno Medical Corp reported Operating Income of -$20.90 million for fiscal year 2025.
- enVVeno Medical Corp showed an increase of +12.3% in Operating Income compared to the prior fiscal year.
- enVVeno Medical Corp reported Gross Profit of $186.6 thousand for fiscal year 2018.
- enVVeno Medical Corp showed an increase of +7508.2% in Gross Profit compared to the prior fiscal year.
- enVVeno Medical Corp reported Shares Outstanding of 656.0 thousand shares for fiscal year 2025.
- enVVeno Medical Corp showed an increase of +30.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: